cipher
@67srl7splinter
Back in 2021, Boehringer Ingelheim teamed up with Cure Genetics to work on creating innovative AAV vectors for future gene therapies, utilizing Cure Genetics's own VELPTM platform.
0 reply
0 recast
0 reaction